First-pass extracted concept

DNA vaccines

Candidate: concept label3 source documents4 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The abstract lists DNA vaccines among the platforms redefining how vaccine antigens are delivered to the immune system.

Source 2DOI PubMed

What problem it solves

They are included within biotechnology approaches aimed at improving vaccine immunogenicity, safety, and accessibility.

Source 2DOI PubMed

Evidence Snippets

Recent advances in nucleic acid-based platforms, particularly mRNA and DNA vaccines, have accelerated clinical translation.

Evidence 1Source 1DOI PubMedprovenance

This review explores the cutting-edge platforms-including mRNA, DNA, virus-like particles, viral and bacterial vectors, and bacteriophage-based vaccines

Evidence 2Source 2DOI PubMedprovenance

Here we review next-generation vaccine strategies, focusing on nucleic acid-based platforms such as mRNA, DNA, and self-amplifying RNA (saRNA), as well as viral vector vaccines.

Evidence 3Source 3DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2primary paper2025MEDDOI PubMed

1 evidence snippet 2 linked claims Claim 1 Claim 2

Source 3primary paper2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1clinical translationsupports2026Source 1DOI PubMed

Recent advances in mRNA and DNA vaccine platforms have accelerated clinical translation of therapeutic cancer vaccines.

Claim 2review scopesupports2025Source 2DOI PubMed

The review covers mRNA, DNA, virus-like particle, viral vector, bacterial vector, and bacteriophage-based vaccine platforms as innovations redefining antigen delivery to the immune system.

Claim 3review scopesupports2025Source 3DOI PubMed

This article reviews next-generation bacterial vaccine strategies including mRNA, DNA, self-amplifying RNA, viral vector vaccines, and nanoparticle technologies.

Quoted textsource-backed

Here we review next-generation vaccine strategies, focusing on nucleic acid-based platforms such as mRNA, DNA, and self-amplifying RNA (saRNA), as well as viral vector vaccines. We also examine nanoparticle technologies that serve as delivery systems or adjuvant platforms across these approaches.

Claim 4summary conclusionsupports2025Source 2DOI PubMed

Biotechnology is enabling the design of safer, more efficient, and more adaptable vaccines to address existing and emerging infectious diseases.